A case report of trastuzumab dose in gastric cancer

Por Kyi, Chrisann, Shah, Manish A.
Publicado em 2013

Role of ((18)F) 2-fluoro-2-deoxyglucose positron emission tomography in upper gastrointestinal malignancies

Por Smyth, Elizabeth C, Shah, Manish A
Publicado em 2011

The Quality of Quality-of-Life and Cost-Effectiveness Analyses

Por Power, Derek G., Kelsen, David P., Shah, Manish A.
Publicado em 2008

Molecular Classification of Gastric Cancer: A new paradigm

Por Shah, Manish A., Khanin, Raya, Tang, Laura, Janjigian, Yelena Y., Klimstra, David S., Gerdes, Hans, Kelsen, David P.
Publicado em 2011

Chemotherapy use, end-of-life care, and costs of care among patients diagnosed with Stage IV pancreatic cancer

Por Bao, Yuhua, Maciejewski, Renee C., Garrido, Melissa M., Shah, Manish A., Maciejewski, Paul K., Prigerson, Holly G.
Publicado no J Pain Symptom Manage (2017)

Positive Peritoneal Cytology in Patients with Gastric Cancer: Natural History and Outcome of 291 Patients

Por Mezhir, James J., Shah, Manish A., Jacks, Lindsay M., Brennan, Murray F., Coit, Daniel G., Strong, Vivian E.
Publicado em 2011

Phase II Study of Modified Docetaxel, Cisplatin, and Fluorouracil With Bevacizumab in Patients With Metastatic Gastroesophageal Adenocarcinoma

Por Shah, Manish A., Jhawer, Minaxi, Ilson, David H., Lefkowitz, Robert A., Robinson, Edric, Capanu, Marinela, Kelsen, David P.
Publicado em 2011

Treatment of resectable gastric cancer

Por Dikken, Johan L., van de Velde, Cornelis J.H., Coit, Daniel G., Shah, Manish A., Verheij, Marcel, Cats, Annemieke
Publicado em 2012

Isolation of breast cancer and gastric cancer circulating tumor cells by use of an anti HER2-based microfluidic device

Por Galletti, Giuseppe, Sung, Matthew S., Vahdat, Linda T., Shah, Manish A., Santana, Steven M., Altavilla, Giuseppe, Kirby, Brian J., Giannakakou, Paraskevi
Publicado em 2013

Identification of low abundance microbiome in clinical samples using whole genome sequencing

Por Zhang, Chao, Cleveland, Kyle, Schnoll-Sussman, Felice, McClure, Bridget, Bigg, Michelle, Thakkar, Prashant, Schultz, Nikolaus, Shah, Manish A., Betel, Doron
Publicado no Genome Biol (2015)

Being present: oncologists' role in promoting advanced cancer patients' illness understanding

Por Cohen, Simon M., Maciejewski, Renee C., Shah, Manish A., Trevino, Kelly M., Shen, Megan J., Maciejewski, Paul K., Prigerson, Holly G.
Publicado no Cancer Med (2018)

Comparison of Disease-Specific Survival in the United States and Korea After Resection for Early-Stage Node-Negative Gastric Carcinoma

Por STRONG, VIVIAN E., SONG, KYO YOUNG, PARK, CHO HYUN, JACKS, LINDSAY M., GONEN, MITHAT, SHAH, MANISH A., COIT, DANIEL G., BRENNAN, MURRAY F.
Publicado em 2012

MET expression and amplification in patients with localized gastric cancer

Por Janjigian, Yelena Y., Tang, Laura H., Coit, Daniel G., Kelsen, David P., Francone, Todd D., Weiser, Martin R., Jhanwar, Suresh C., Shah, Manish A.
Publicado em 2011

A Randomized Phase II Study of FOLFOX With or Without the MET Inhibitor Onartuzumab in Advanced Adenocarcinoma of the Stomach and Gastroesophageal Junction

Por Shah, Manish A., Cho, Jae-Yong, Tan, Iain B., Tebbutt, Niall C., Yen, Chia-Jui, Kang, Alice, Shames, David S., Bu, Lilian, Kang, Yoon-Koo
Publicado no Oncologist (2016)

A Phase 2 Study of Flavopiridol (Alvocidib) in Combination with Docetaxel in Refractory, Metastatic Pancreatic Cancer (NCI#6366)

Por Carvajal, Richard D., Tse, Archie, Shah, Manish A., Lefkowitz, Robert A., Gonen, Mithat, Gilman-Rosen, Lisa, Kortmansky, Jeremy, Kelsen, David P., Schwartz, Gary K., O'Reilly, Eileen M.
Publicado em 2009

Conditional Probability of Survival Nomogram for 1-, 2-, and 3-Year Survivors After an R0 Resection for Gastric Cancer

Por Dikken, Johan L., Baser, Raymond E., Gonen, Mithat, Kattan, Michael W., Shah, Manish A., Verheij, Marcel, van de Velde, Cornelis J. H., Brennan, Murray F., Coit, Daniel G.
Publicado em 2012

Impact of Patient Factors on Recurrence Risk and Time Dependency of Oxaliplatin Benefit in Patients With Colon Cancer: Analysis From Modern-Era Adjuvant Studies in the Adjuvant Col...

Por Shah, Manish A., Renfro, Lindsay A., Allegra, Carmen J., André, Thierry, de Gramont, Aimery, Schmoll, Hans-Joachim, Haller, Daniel G., Alberts, Steven R., Yothers, Greg, Sargent, Daniel J.
Publicado no J Clin Oncol (2016)

A phase I clinical trial of FOLFIRI in combination with the pan-cyclin-dependent kinase (CDK) inhibitor flavopiridol

Por Dickson, Mark A., Shah, Manish A., Rathkopf, Dana, Tse, Archie, Carvajal, Richard D., Wu, Nian, Lefkowitz, Robert A., Gonen, Mithat, Cane, Lauren M., Dials, Heather J., Schwartz, Gary K.
Publicado em 2010

Effect of Fluorouracil, Leucovorin, and Oxaliplatin With or Without Onartuzumab in HER2-Negative, MET-Positive Gastroesophageal Adenocarcinoma: The METGastric Randomized Clinical T...

Por Shah, Manish A., Bang, Yung-Jue, Lordick, Florian, Alsina, Maria, Chen, Meng, Hack, Stephen P., Bruey, Jean Marie, Smith, Dustin, McCaffery, Ian, Shames, David S., Phan, See, Cunningham, David
Publicado no JAMA Oncol (2016)

Phase I study of epigenetic priming with azacitidine prior to standard neoadjuvant chemotherapy for patients with resectable gastric and esophageal adenocarcinoma: Evidence of tumo...

Por Schneider, Bryan J., Shah, Manish A., Klute, Kelsey, Ocean, Allyson, Popa, Elizabeta, Altorki, Nasser, Lieberman, Michael, Schreiner, Andrew, Yantiss, Rhonda, Christos, Paul J., Palmer, Romae, You, Daoqi, Viale, Agnes, Kermani, Pouneh, Scandura, Joseph M.
Publicado no Clin Cancer Res (2016)